25th Aug 2026 12:17
Nuformix PLC - London-based pharmaceutical development company focused on fibrosis and oncology via drug repurposing - Hires Tim Metcalfe to be non-executive chair, starting September 1, Tuesday next week. Metcalfe is a corporate financier who among other City roles was joint CEO of Zeus Capital Ltd. At Nuformix, he replaces Julian Gilbert, who is stepping down for "personal reasons". Gilbert has been on the board since 2020 and chair since 2022.
Current stock price: 0.17 pence, up 1.1% on Tuesday afternoon in London
12-month change: up from 0.070p
By Tom Waite, Alliance News editor
Comments and questions to [email protected]
Copyright 2026 Alliance News Ltd. All Rights Reserved.
Related Shares:
Nuformix